CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Aug. 31, 2021	Aug. 31, 2020
Revenues:
Total Revenue	$ 1,601,037	$ 27,004
Cost of Goods Sold	1,416,779	24,521
Gross Profit	184,258	2,483
Operating Expenses:
Advertising Expenses	64,667	213,302
Consulting Services	305,413	2,033,801
Professional Fees	481,368	717,548
General and Administrative Expenses	1,276,734	661,724
Total Operating Expenses	2,128,182	3,626,375
Operating Loss	(1,943,924)	(3,623,892)
Other Income (Expense)
Interest expense	(7,437,340)	(1,422,469)
Gain (loss) on Debt Cancellation	(36,841)	45,745
Changes in Fair Value of Derivatives	2,022,060	111,268
Uncollectible Note Receivable	0	(40,000)
Loss on Investment	(55,435)	0
Loss on Acquisition	(454,768)	0
Equity method loss	(211,376)	0
Other Income	1,642	0
Total Other Income (Expense)	(6,172,058)	(1,305,456)
Net Loss	(8,115,982)	(4,929,348)
Net Loss Attributable to Noncontrolling Interest	281,143	0
Net Loss Attributable to Cannabis Global, Inc.	$ (7,834,839)	$ (4,929,348)
Basic & Diluted Loss per Common Share	$ (0.13)	$ (0.29)
Weighted Average Common Shares Outstanding	58,288,760	17,101,743
Product Sales [Member]
Revenues:
Total Revenue	$ 1,601,037	$ 970,717